242 related articles for article (PubMed ID: 25791792)
1. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
Yoo C; Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S362-9. PubMed ID: 25791792
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
4. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
Wu X; Li J; Xu W; Gao J; Li Y; Shen L
Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
[TBL] [Abstract][Full Text] [Related]
5. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and prognosis of primary gastrointestinal stromal tumor patients under 35 years of age: A 10-year retrospective study.
Zhang P; Deng R; Liu K; Shuai XM; Bai J; Chang WL; Gao JB; Cai KL; Wang GB; Tao KX
J Surg Oncol; 2016 Dec; 114(8):977-981. PubMed ID: 27664034
[TBL] [Abstract][Full Text] [Related]
9. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
[TBL] [Abstract][Full Text] [Related]
11. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS
Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
14. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
López RL; del Muro XG
Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
[TBL] [Abstract][Full Text] [Related]
17. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumor of the small intestine: a clinicopathologic study of 70 cases in the postimatinib era.
Huang CC; Yang CY; Lai IR; Chen CN; Lee PH; Lin MT
World J Surg; 2009 Apr; 33(4):828-34. PubMed ID: 19198935
[TBL] [Abstract][Full Text] [Related]
19. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
[TBL] [Abstract][Full Text] [Related]
20. Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
Stuart E; Banerjee S; de la Torre J; Wang Y; Scherzer N; Burgoyne AM; Parry L; Fanta PT; Ramamoorthy S; Sicklick JK
J Surg Oncol; 2019 Sep; 120(4):715-721. PubMed ID: 31297829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
